HIV News and Research

RSS

Scientists discover new anti-tuberculosis compound that kills drug-resistant TB bacteria

An international team led by scientists at The Scripps Research Institute (TSRI), the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways.

18 Jun 2013

Bioapplications of nanoparticles: an interview with Dr Catherine Berry, University of Glasgow

These particles are all classed as inorganic particles, which can all be utilised in biomedical applications. They differ in terms of their inherent material and size dependent physiochemical properties, for example, their optical and magnetic properties.

18 Jun 2013

Age disparities exist in continuum of care for patients with HIV

Age disparities exist in the continuum of care for patients with the human immunodeficiency virus (HIV) with people younger than 45 years less likely to be aware of their infection or to have a suppressed viral load, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

18 Jun 2013

TSRI scientists identify highly promising new anti-tuberculosis compound

An international team led by scientists at The Scripps Research Institute, the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis bacterium in two different ways.

18 Jun 2013

Malaria control strategies: an interview with Sir Richard Feachem, Global Health Group, University of California, San Francisco

Exciting progress has been made in the global fight against malaria. The malaria map continues to shrink each year; in the last ten years four countries have been certified malaria-free, and thirty-four additional countries are now working towards malaria elimination targets.

17 Jun 2013

HIV prevention programs for female sex workers in India reduce syphilis, HIV

HIV prevention programs for female sex workers in India reduce rates of syphilis, HIV and other sexually transmitted infections (STIs), a University of Toronto study has found.

17 Jun 2013

Drug Innovation Ventures provides development and commercialization solutions for traditional academic drug discovery

Emory University today announced an innovative new public-private drug development enterprise that will transition scientific discoveries more rapidly and efficiently from university laboratories into the marketplace. The new venture is expected to provide global solutions to address worldwide drug development and commercialization needs.

15 Jun 2013

New research finding raises questions about common mutant forms of JC polyomavirus

The JC polyomavirus is clearly opportunistic. It infects half the population but lethally destroys brain tissue only in immunocompromised patients - and it may be outright sneaky, too. Even as a new research paper allays fears that common mutant forms of the virus are the ones directly responsible for the disease's main attack, that same finding raises new questions about what the mutants are doing instead.

14 Jun 2013

Wis. lawmakers poised to OK bill that will require ultrasound before abortion

Wisconsin lawmakers appear poised to approve a measure supported by the governor that would require women seeking an abortion get an ultrasound before the procedure.

13 Jun 2013

WHO issues interim policy guidance on inclusion of bedaquiline to treat adults with MDR-TB

WHO estimates that up to half a million new cases of multidrug-resistant tuberculosis occur worldwide, each year. Current treatment regimens for MDR-TB present many challenges: treatment lasts 20 months or more, requiring daily administration of drugs that are more toxic, less effective, and far more expensive than those used to treat drug-susceptible TB.

13 Jun 2013

Research sheds light on the details of austerity cuts in Spanish health system

A series of austerity reforms made by the Spanish government could lead to the effective dismantling of large parts of the country's healthcare system, with potentially detrimental effects on the health of the Spanish people, according to new research published in BMJ.

13 Jun 2013

Short self-defense course reduces Kenyan girls' vulnerability to sexual assault

Rape is shockingly common in the slums of Nairobi, Kenya, where as many as one in four adolescent girls are raped each year. But a short self-defense course can dramatically reduce the girls' vulnerability to sexual assault, according to a new study from the Stanford University School of Medicine, Lucile Packard Children's Hospital and an organization called No Means No Worldwide.

13 Jun 2013

Hebrew University student develops drug formulations to treat illnesses through skin applications

New, more efficient drug formulations designed to treat illnesses through skin applications -- thus avoiding serious side effects associated with oral drug-taking -- have been developed by a student at the Hebrew University of Jerusalem.

12 Jun 2013

Integrating exercise into cancer follow-up care can improve recovery, say Miriam Hospital researchers

Telephone-based counseling, when combined with physician advice, can help breast cancer survivors become more physically active, which can improve quality of life and lessen the side effects of cancer treatment, according to new research from The Miriam Hospital.

12 Jun 2013

Johns Hopkins researchers develop experimental vaccine for TB meningitis

A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately occurs in TB-infected children and in adults with compromised immune system.

12 Jun 2013

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

Cerus Corporation announced today that it has initiated patient enrollment in two European Phase III clinical trials for the INTERCEPT System for red blood cells.

11 Jun 2013

European Commission grants orphan drug designation for maribavir for treatment of CMV disease

ViroPharma Incorporated today announced that the European Commission has granted orphan drug designation for maribavir for treatment of cytomegaloviral disease in patients with impaired cell mediated immunity.

11 Jun 2013

Study explores various strategies, suggests cost-effective options for HIV testing in India

In India most people who are HIV positive don't know it, yet testing and treatment are relatively cheap and available. It would therefore meet international standards of cost-effectiveness - and save millions of lives for decades - to test every person in the billion-plus population every five years according to a new study published in the journal PLoS One.

11 Jun 2013

3 out of 20 GI endoscopes used for screening harbor unacceptable levels of "bio dirt"

Three out of 20 flexible gastrointestinal (GI) endoscopes used for screening were found to harbor unacceptable levels of "bio dirt" - cells and matter from a patient's body that could pose potential infection risk -- according to a study of endoscopes used at five hospitals across the U.S.

10 Jun 2013

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.

10 Jun 2013

HIV News and Research

Scientists discover new anti-tuberculosis compound that kills drug-resistant TB bacteria

Bioapplications of nanoparticles: an interview with Dr Catherine Berry, University of Glasgow

Age disparities exist in continuum of care for patients with HIV

TSRI scientists identify highly promising new anti-tuberculosis compound

Malaria control strategies: an interview with Sir Richard Feachem, Global Health Group, University of California, San Francisco

HIV prevention programs for female sex workers in India reduce syphilis, HIV

Drug Innovation Ventures provides development and commercialization solutions for traditional academic drug discovery

New research finding raises questions about common mutant forms of JC polyomavirus

Wis. lawmakers poised to OK bill that will require ultrasound before abortion

WHO issues interim policy guidance on inclusion of bedaquiline to treat adults with MDR-TB

Research sheds light on the details of austerity cuts in Spanish health system

Short self-defense course reduces Kenyan girls' vulnerability to sexual assault

Hebrew University student develops drug formulations to treat illnesses through skin applications

Integrating exercise into cancer follow-up care can improve recovery, say Miriam Hospital researchers

Johns Hopkins researchers develop experimental vaccine for TB meningitis

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

European Commission grants orphan drug designation for maribavir for treatment of CMV disease

Study explores various strategies, suggests cost-effective options for HIV testing in India

3 out of 20 GI endoscopes used for screening harbor unacceptable levels of "bio dirt"

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News